ENTROPY NEURODYNAMICS LIMITED — Capital/Financing Update 2019

Jul 21, 2019

Market Announcement

==> picture [33 x 50] intentionally omitted <==

22 July 2019

==> picture [451 x 5] intentionally omitted <==

Exopharm Limited (ASX: EX1) – Trading Halt

Description

The securities of Exopharm Limited (‘EX1’) will be placed in trading halt at the request of EX1, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 24 July 2019 or when the announcement is released to the market.

Issued by

Isabelle Andrews

Senior Adviser, Listings Compliance (Perth)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

22 July 2019 ASX Limited

==> picture [595 x 77] intentionally omitted <==

20[nd] July 2019

Anjuli Sinniah Senior Adviser, Listing Compliance (Perth) ASX Compliance Pty Limited Level 40, Central Park 152-158 St Georges Terrace Perth WA 6000

Via Email: tradinghaltsperth@asx.com.au Anjuli.Sinniah@asx.com.au

EXOPHARM LIMITED (ASX:EX1) REQUEST FOR TRADING HALT

Exopharm Limited (‘Exopharm’ or the ‘Company’) requests a halt in trading of its securities, pending the Company making an announcement regarding a capital raising (Capital Raising).

In accordance with Listing Rule 17.1, the Company provides the following information regarding this request:

1. The Company requests that the trading halt continue until the earlier of the commencement of trading on Wednesday 24[th] July 2019 and the release of an announcement regarding the Capital Raising, whichever is the earlier.

2. The event that the Company expects will end the trading halt is the announcement referred to in paragraph 1 above.

3. The Company is not aware of any reasons why the trading halt should not be granted.

Yours Sincerely EXOPHARM LIMITED

==> picture [97 x 41] intentionally omitted <==

David Parker NED & Company Secretary

1

EXOPHARM LIMITED ACN: 163 765 991 ASX:EX1 Address: Level 17, 31 Queen Street Melbourne 3000 Telephone: 03 9111 0026 Email: info@exopharm.com Web: www.exopharm.com